Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;382(2):177-91.
doi: 10.1007/s00210-010-0534-5. Epub 2010 Jul 9.

Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands

Sarah Geiger  1 , Kathrin Nickl, Erich H Schneider, Roland Seifert, Jörg Heilmann
Affiliations

Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands

Sarah Geiger et al. Naunyn Schmiedebergs Arch Pharmacol. 2010 Aug.

Abstract

Cannabinoid receptors (CBR) are important drug targets for the treatment of various inflammatory, metabolic and neurological diseases. Therefore, sensitive test systems for the assessment of ligands are needed. In this study, a steady-state GTPase assay for human CBR subtypes 1 and 2 was developed to characterize the pharmacological property of ligands at a very proximal point of the signal transduction cascade. Establishing these in vitro test sytems, we studied cell or tissue membranes heterogenously or endogenously expressing CBR, such as CBR-infected Human Embryonic Kidney (HEK) 293 cells, rat cerebellum and spleen cells. The lack of effects in the GTPase assay and in [(35)S]GTPgammaS binding experiments in these expression system, directed us to use Spodoptera frugiperda (Sf9) cells. Co-expressing CBR, different Galpha-subunits, Gbetagamma heterodimer, and RGS (Regulator of G-protein signaling)-proteins in Sf9 cell membranes greatly improved the sensitivity of the assay, with highest GTPase activation in the CBR + Galpha(i2) + Gbeta(1)gamma(2) + RGS4 system. We examined exogenous and endogenous standard ligands as well as secondary metabolites as Delta(9)-tetrahydrocannabinol (Delta(9)-THC), dodeca-2E,4E-dienoic acid isobutylamide, an alkylamide from Echinacea purpurea, and an E. purpurea hexane extract according their agonistic and antagonistic properties. The suitability of the assay for screening procedures was also proven by detecting the activity of Delta(9)-THC in a matrix of other less active compounds (Delta(9)-THC-free Cannabis sativa extract). In conclusion, we have developed highly sensitive test systems for the analysis of CBR ligands.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Trends Pharmacol Sci. 1999 Sep;20(9):383-9 - PubMed
    1. Biochemistry. 2009 Feb 17;48(6):1424-38 - PubMed
    1. Br J Pharmacol. 2008 Jan;153(2):199-215 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):261-74 - PubMed
    1. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3984-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources